Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.

@article{Fielding2011SarcopeniaAU,
  title={Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.},
  author={Roger A Fielding and Bruno Vellas and William J Evans and Shalender Bhasin and John E. Morley and Anne B. Newman and Gabor Abell{\'a}n van Kan and Sandrine Andrieu and Juergen M. Bauer and Denis Breuill{\'e} and Tommy Cederholm and Julie M. Chandler and C de Meynard and Lorenzo Maria Donini and Tamara B. Harris and Aimo Kannt and Florence Keime Guibert and Graziano Onder and Dimitris A. Papanicolaou and Yves Rolland and Daniel S Rooks and Cornel C Sieber and Elisabeth Souhami and Sjors Verlaan and Mauro Zamboni},
  journal={Journal of the American Medical Directors Association},
  year={2011},
  volume={12 4},
  pages={
          249-56
        }
}

Tables from this paper

Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations.

TLDR
How sarcopenia screening is aided by the new ICD-10-CM code is informed and recent VA initiatives for proactive care are reviewed to help practitioners better understand clinically viable and valid methods to screen and diagnose this geriatric syndrome.

Sarcopenia Updates in Concept, Diagnosis, and Treatment: Could Medium Chain Triglycerides Be a Treatment Candidate for Sarcopenia?

TLDR
Medium chain triglyceride (MCT), a lipid of carbon chain 8-10, has high energy efficiency, and is used immediately as an energy source, and MCT is considered to be one of extremely useful nutrients for the elderly with malnutrition and sarcopenia with decreased food intake.

Sarcopenia: assessment of disease burden and strategies to improve outcomes

TLDR
Because sarcopenia is associated with important adverse health outcomes, such as frailty, hospitalization, and mortality, several therapeutic strategies have been identified that involve exercise training, nutritional supplementation, hormonal therapies, and novel strategies and are still under investigation.

Clinical definition of sarcopenia.

  • V. SantilliA. BernettiM. MangoneM. Paoloni
  • Medicine
    Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases
  • 2014
TLDR
There is an important correlation between inactivity and losses of muscle mass and strength, this suggests that physical activity should be a protective factor for the prevention but also the management of sarcopenia.

Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.

Sarcopenia: Its definition, prevalence, functional outcomes and prevention

TLDR
There is an urgent need to establish a consensus on the definition of sarcopenia for those of Asian descent, and effective programs are now being developed, some of which use progressive resistance training in combination with specific nutrient supplementations.

Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults

TLDR
It is hypothesised that hospitalisation, due to a combination of acute inflammatory burden and muscle disuse, leads to an acute decline in muscle mass and function and may lead to some individuals meeting criteria for sarcopenia, acutely, based on the EWGSOP definition.

Definitions of Sarcopenia: Associations with Previous Falls and Fracture in a Population Sample

TLDR
The IWGS definition of sarcopenia appears to be an effective means of identifying individuals at risk of prevalent adverse musculoskeletal events and was applied to participants from the Hertfordshire Cohort Study.

Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People

TLDR
Older adults with severe sarcopenia and those with changes in physical performance had an increased risk of death in the short term and there was no statistically significant association between the other sarc Openia components and mortality risk.
...

References

SHOWING 1-10 OF 107 REFERENCES

Epidemiology of sarcopenia among the elderly in New Mexico.

TLDR
Some of the first estimates of the extent of the public health problem posed by sarcopenia are provided, independent of ethnicity, age, morbidity, obesity, income, and health behaviors.

Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia.

TLDR
Optimal cutoff values that can be used in the clinical practice to identify older persons with poor mobility were developed and lay the basis for a cost-effective, clinical marker of sarcopenia based on a measure of isometric handgrip strength.

From the Chicago MeetingsSarcopenia

Sarcopenia is a term utilized to define the loss of muscle mass and strength that occurs with aging. Sarcopenia is believed to play a major role in the pathogenesis of frailty and functional

Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women.

TLDR
Results of the present study provide further evidence that sarcopenia exists even among otherwise healthy women with increasing age-specific prevalence and to find therapeutic strategies with beneficial effects in conserving skeletal muscle mass.

Sarcopenia and aging.

TLDR
Preliminary studies show that the utilization of several trophic factors, notably testosterone and DHEA, may have a salutary effect on muscle mass and/or strength in older adults, but more research is needed before drawing definite conclusion as to the clinical utility of these substances in the management of sarcopenia.

Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.

TLDR
Sarcopenia is common in adults over the age of 65 years and increases with age in women and men and interventions to target nutrition, strength training, and testosterone replacement therapy should be further investigated for their role in preventing muscle loss with age.

Epidemiology of sarcopenia.

What is sarcopenia?

  • W. Evans
  • Medicine
    The journals of gerontology. Series A, Biological sciences and medical sciences
  • 1995
TLDR
Data indicate that preservation of muscle mass and prevention of sarcopenia can help prevent the decrease in metabolic rate in the elderly.

Sarcopenia in elderly men and women: the Rancho Bernardo study.

Sarcopenia is predictive of nosocomial infection in care of the elderly

TLDR
Sarcopenia on admission to an acute care of the elderly unit, as measured by X-ray absorptiometry, was associated with a doubled risk of NI during the first 3 weeks of hospitalisation, and none of the other morphometric or biological parameters differed significantly.
...